Bristol-Myers Squibb Company (BMY) vs Intuitive Surgical, Inc. (ISRG)
A side-by-side comparison of Bristol-Myers Squibb Company and Intuitive Surgical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
BMY
Bristol-Myers Squibb Company
$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
ISRG
Intuitive Surgical, Inc.
$369.15HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — BMY vs ISRG
growth of $100 · dividends reinvested · last 10yBMY +60.4% (+4.8%/yr)ISRG +372.7% (+16.8%/yr)ISRG compounded faster over this window
BMY ISRG
BMY vs ISRG: by the numbers
- •ISRG is the larger company ($130.41B vs $130.00B market cap).
- •BMY trades at the lower trailing earnings multiple (14.02 vs 42.00 P/E), one valuation lens rather than an overall verdict.
- •ISRG converts more revenue to profit (28.45% vs 18.87% net margin).
- •ISRG grew revenue faster over the past five years (16.41% vs 2.08% CAGR).
- •BMY pays a dividend (3.94% yield), while ISRG has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BMY | ISRG |
|---|---|---|
| P/E ratio | 14.02 | 42.00 |
| Forward P/E | 9.18 | 34.18 |
| P/S ratio | 2.64 | 11.82 |
| P/B ratio | 5.82 | 7.18 |
| EV / EBITDA | 9.71 | 30.16 |
| FCF yield | 8.80% | 2.47% |
Profitability
| Metric | BMY | ISRG |
|---|---|---|
| Gross margin | 70.16% | 66.68% |
| Operating margin | 28.27% | 31.28% |
| Net margin | 18.87% | 28.45% |
| ROE | 41.59% | 17.28% |
| ROIC | 15.47% | 15.11% |
Dividends
| Metric | BMY | ISRG |
|---|---|---|
| Dividend yield | 3.94% | N/A |
| Payout ratio | 55.29% | N/A |
Growth (annualized)
| Metric | BMY | ISRG |
|---|---|---|
| Revenue CAGR (5Y) | 2.08% | 16.41% |
| EPS CAGR (5Y) | 9.38% | 21.51% |
| FCF CAGR (5Y) | -0.95% | 14.17% |
| Total return CAGR (5Y) | 4.39% | 1.11% |
Frequently asked
- Which has the lower trailing P/E, BMY or ISRG?
- BMY has the lower trailing P/E: BMY trades at 14.02 and ISRG at 42.00. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BMY or ISRG?
- Over the past five years, ISRG grew revenue faster — BMY at a 2.08% CAGR versus ISRG at 16.41%.
- Does BMY or ISRG pay a bigger dividend?
- BMY pays a dividend (3.94% yield), while ISRG has no payments in the available dividend history.
- Is BMY or ISRG more profitable?
- ISRG runs the higher net margin — BMY at 18.87% versus ISRG at 28.45%.
- How have BMY and ISRG total returns compared?
- Over the past 10 years, BMY delivered 5.01% and ISRG delivered 16.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioIntuitive Surgical P/E ratioBristol-Myers Squibb dividend yieldBristol-Myers Squibb ROEIntuitive Surgical ROEBristol-Myers Squibb operating marginIntuitive Surgical operating marginBristol-Myers Squibb revenue growthIntuitive Surgical revenue growthBristol-Myers Squibb free cash flowIntuitive Surgical free cash flow
Bristol-Myers Squibb & Intuitive Surgical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.